Alere 8-K Inverness Medical Innovations Announces First Quarter 2008 Results

Exhibit 99.2

Inverness Medical Innovations, Inc. and Subsidiaries
Condensed Consolidated Statements of Operations
(in $000s, except per share amounts)

	Three Months Ended March 31,
	2008			2007
	(unaudited)			(unaudited)
Net revenue	$	372,233		$	158,979
Cost of revenue		191,843			80,641
Gross profit		180,390			78,338
Gross margin		48	%		49	%
Operating expenses:
Research and development		30,925			12,009
Selling, general and administrative		134,687			50,990
Total operating expenses		165,612			62,999
Operating income		14,778			15,339
Interest and other income (expense), net		(20,995	)		(3,155	)
Income tax (benefit) provision		(880	)		5,879
Equity earnings of unconsolidated entities, net of tax		1,163			—
Net (loss) income	$	(4,174	)	$	6,305
Net (loss) income per common share:
Basic	$	(0.05	)	$	0.14
Diluted	$	(0.05	)	$	0.14
Weighted average shares — basic		77,244			44,446
Weighted average shares — diluted		77,244			46,198

Inverness Medical Innovations, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(in $000s)

	March 31,		December 31,
	2008(1)		2007(1)
	(unaudited)		(unaudited)
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$	402,877	$	414,732
Restricted cash		1,869		141,869
Marketable securities		1,995		2,551
Accounts receivable, net		198,549		163,380
Inventories, net		156,291		148,231
Prepaid expenses and other current assets		142,853		82,211
Total current assets		904,434		952,974
PROPERTY, PLANT AND EQUIPMENT, NET		273,039		267,880
GOODWILL AND OTHER INTANGIBLE ASSETS, NET		3,704,123		3,494,174
DEFERRED FINANCING COSTS AND OTHER ASSETS, NET		151,839		165,731
Total assets	$	5,033,435	$	4,880,759
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Current portion of notes payable	$	21,676	$	21,096
Other current liabilities		330,967		257,812
Total current liabilities		352,643		278,908
LONG-TERM LIABILITIES:
Notes payable, net of current portion		1,372,863		1,366,753
Deferred tax liability		363,640		326,128
Other long-term liabilities		332,098		322,303
Total long-term liabilities		2,068,601		2,015,184
TOTAL STOCKHOLDERS’ EQUITY		2,612,191		2,586,667
Total liabilities and stockholders’ equity	$	5,033,435	$	4,880,759

⁽¹⁾ December 31, 2007 amounts have been adjusted to reflect the correction of certain errors and their related estimated tax effects. The Company will amend its Form 10-K to correct its previously reported results. Amounts presented above related to the estimated tax effects of the corrections may differ from those included in the amended Form 10-K upon finalization of the restatement.